SCHEMBL14422195

SCHEMBL14422195

Cc1nc(Cc2c(Cl)cccc2Cl)sc1C(=O)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.65
▸ MAPT P10636 7/20 0.58
▸ MEN1 O00255 4/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ NR1H4 Q96RI1 1/20 0.54
▸ PPARA Q07869 4/20 0.52
▸ ALDH1A1 P00352 4/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ HTT P42858 3/20 0.49
▸ LMNA P02545 2/20 0.49
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ PPARG P37231 1/20 0.45
▸ PPARD Q03181 1/20 0.45
▸ POLB P06746 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14422228 0.80 LMNA (0.56) MAPTKMT2ANR1H4ALDH1A1NPC1
SCHEMBL14422197 0.79 TRPV1 (0.47) AHRMAPTMEN1KMT2ANPC1
SCHEMBL5216624 0.76 SMN1; SMN2 (0.54) MAPTKMT2ANR1H4ALDH1A1NPC1
SCHEMBL5213978 0.75 MAPT (0.48) MAPTMEN1KMT2AALDH1A1NPC1
SCHEMBL14422204 0.73 TRPV1 (0.46) AHRMAPTNPC1LMNA
SCHEMBL14422198 0.71 TRPV1 (0.48) NPC1
SCHEMBL14422231 0.71 LMNA (0.56) MAPTKMT2AALDH1A1NPC1GAA
SCHEMBL5215713 0.71 ALDH1A1 (0.34) AHRPPARAALDH1A1NPC1GAA
SCHEMBL14422226 0.71 RORC (0.54) MAPTKMT2AALDH1A1NPC1GAA
SCHEMBL3117820 0.70 TRPV1 (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265138-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2007-09-04 — — US disclosed
US-7265138-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2007-09-04 — — US disclosed
EP-1818333-A1 Vanilloid receptor ligands and their use in treatments Amgen Inc. (US) 2007-08-15 — — EP disclosed
Send feedback